Iron regulatory protein 2 is involved in brain copper homeostasis

Journal of Alzheimer's Disease

Volumn 18, Issue 1, 2009, Pages 201-210

  Mueller, Claudius ^a,c   Magaki, Shino ^a   Schrag, Matthew ^a   Ghosh, Manik C ^b   Kirsch, Wolff M ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Amyloid protein precursor (A PP); Iron regulatory protein 2 (IRP2)

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COPPER; IRON; IRON REGULATORY PROTEIN 2;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; HIPPOCAMPUS; HOMEOSTASIS; MALE; MOUSE; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; RNA TRANSLATION; THALAMUS; UPREGULATION;

EID: 70349094837     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1136     Document Type: Article

References (56)

1. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O'Halloran TV (1999) Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284, 805-808.
2. Hamza I, Schaefer M, Klomp LW, Gitlin JD (1999) Interaction of the copper chaperone HAH1 with the Wilson disease protein is essential for copper homeostasis. Proc Natl Acad Sci USA 96, 13363-13368.
3. Hesse L, Beher D, Masters CL, Multhaup G (1994) The beta A4 amyloid precursor protein binding to copper. FEBS Lett 349, 109-116.
4. Multhaup G, Schlicksupp A, Hesse L, Beher D, Ruppert T, Masters CL, Beyreuther K (1996) The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271, 1406-1409. (Pubitemid 26089474)
5. Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fair-lie DP, Tanzi RE, Bush AI (2000) Characterization of copper interactions with Alzheimer amyloid beta peptides: identifi-cation of an attomolar-affinity copper binding site on amyloid beta1-42. J Neurochem 75, 1219-1233.
6. Barnham KJ, McKinstry WJ, Multhaup G, Galatis D, Morton CJ, Curtain CC, Williamson NA, White AR, Hinds MG, Norton RS, Beyreuther K, Masters CL, Parker MW, Cappai R (2003) Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. J Biol Chem 278, 17401-17407.
7. Bayer TA, Multhaup G (2005) Involvement of amyloid beta precursor protein (AbetaPP) modulated copper homeostasis in Alzheimer's disease. J Alzheimers Dis 8, 201-206.
8. White AR, Reyes R, Mercer JF, Camakaris J, Zheng H, Bush AI, Multhaup G, Beyreuther K, Masters CL, Cappai R (1999) Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res 842, 439-444.
9. Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, Masters CL, Bush AI, Li QX (2002) Overex-pression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem 277, 44670-44676.
10. Phinney AL, Drisaldi B, Schmidt SD, Lugowski S, Coronado V, Liang Y, Horne P, Yang J, Sekoulidis J, Coomaraswamy J, Chishti MA, Cox DW, Mathews PM, Nixon RA, Carlson GA, St George-Hyslop P, Westaway D (2003) In vivo reduction of amyloid-beta by a mutant copper transporter. Proc Natl Acad Sci USA 100, 14193-14198.
11. Bayer TA, Schafer S, Simons A, Kemmling A, Kamer T, Tepest R, Eckert A, Schussel K, Eikenberg O, Sturchler-Pierrat C, Abramowski D, Staufenbiel M, Multhaup G (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci USA 100, 14187-14192.
12. Bellingham SA, Ciccotosto GD, Needham BE, Fodero LR, White AR, Masters CL, Cappai R, Camakaris J (2004) Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts. J Neu-rochem 91, 423-428.
13. Meyron-Holtz EG, Ghosh MC, Iwai K, LaVaute T, Brazzolotto X, Berger UV, Land W, Ollivierre-Wilson H, Grinberg A, Love P, Rouault TA (2004) Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 23, 386-395.
14. Recalcati S, Alberghini A, Campanella A, Gianelli U, De CE, Conte D, Cairo G (2006) Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency. Haematologica 91, 303-310.
15. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, Gullans SR (2002) An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem 277, 45518-45528.
16. Reznichenko L, Amit T, Zheng H, vramovich-Tirosh Y, Youdim MB, Weinreb O, Mandel S (2006) Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease. J Neurochem 97, 527-536.
17. Hart E, Steenbock H, Waddell J, Elvehjem C (1928) Iron in nutrition. VII. Copper as a supplement to iron for hemoglobin building in the rat. J Biol Chem 77, 797-833.
18. Millon E (1848) De la presence normale de plusiers metaux dans le sang de l'homme, et de l'analyse des sels fixes contenus dans ce liquide. Comptes Rend de l'Acad des Sci a Paris, 41-43.
19. Fox PL (2003) The copper-iron chronicles: the story of an intimate relationship. Biometals 16, 9-40.
20. Warburg O, Krebs H (1927) Ueber locker gebundenes Kupfer und Eisen im Blutserum. Biochem Z, 143-149.
21. Iwanska S, Strusinska D (1978) Copper metabolism in different states of erythropoiesis activity. Acta Physiol Pol 29, 465-474
22. Collins JF (2006) Gene chip analyses reveal differential genetic responses to iron deficiency in rat duodenum and jejunum. Biol Res 39, 25-37.
23. LaVaute T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, Drake SK, Miller G, Abu-Asab M, Tsokos M, Switzer R, Grinberg A, Love P, Tresser N, Rouault TA (2001) Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 27, 209-214.
24. Magaki S, Mueller C, Yellon SM, Fox J, Kim J, Snissarenko E, Chin V, Ghosh MC, Kirsch WM (2007) Regional dissection and determination of loosely bound and non-heme iron in the developing mouse brain. Brain Res 1158, 144-150.
25. Paxinos G, Franklin KB (2002) The Mouse Brain in Stereo-taxic Coordinates: Compact Second Edition. 120.
26. Levites Y, Amit T, Mandel S, Youdim MB (2003) Neuro-protection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3- gallate. FASEB J 17, 952-954.
27. Hilbich C, Monning U, Grund C, Masters CL, Beyreuther K (1993) Amyloid-like properties of peptides flanking the epi-tope of amyloid precursor protein-specific monoclonal antibody 22C11. J Biol Chem 268, 26571-26577.
28. Pantopoulos K, Hentze MW (1998) Activation of iron regulatory protein-1 by oxidative stress in vitro. Proc Natl Acad Sci USA 95, 10559-10563.
29. Galy B, Hoelter SM, Klopstock T, Ferring D, Becker L, Kaden S, Wurst W, Groene H, Hentze MW (2006) Iron homeostasis in the brain: complete iron regulatory protein 2 deficiency without symptomatic neurodegeneration in the mouse. Nat Genet 38, 967-969; discussion 969-970.
30. Ghosh MC, Ollivierre-Wilson H, Cooperman S, Rouault TA (2006) Reply to Iron homeostasis in the brain: complete iron regulatory protein 2 deficiency without symptomatic neurode-generation in the mouse. Nat Genet 38, 969-970.
31. Smith SR, Cooperman S, Lavaute T, Tresser N, Ghosh M, Meyron-Holtz E, Land W, Ollivierre H, Jortner B, Switzer R, Messing A, Rouault TA (2004) Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Ann N Y Acad Sci 1012, 65-83.
32. Ono S, Koropatnick DJ, Cherian MG (1997) Regional brain distribution of metallothionein, zinc and copper in toxic milk mutant and transgenic mice. Toxicology 124, 1-10.
33. Prohaska JR, Lukasewycz OA (1990) Effects of copper defi-ciency on the immune system. Adv Exp Med Biol 262, 123-143.
34. Jones LC, Beard JL, Jones BC (2008) Genetic analysis reveals polygenic influences on iron, copper, and zinc in mouse hip-pocampus with neurobiological implications. Hippocampus 18, 398-410.
35. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 47-52.
36. Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3, 205-214.
37. Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 143, 137-142.
38. Magaki S, Raghavan R, Mueller C, Oberg KC, Vinters HV, Kirsch WM (2007) Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias. Neurosci Lett 418, 72-76.
39. Plantin, Lying-Tunell, Kristensson (1987) Trace elements in the human central nervous system studied with neutron activation analysis. Biol Trace Elem Res 13, 69-75.
40. Thompson CM, Markesbery WR, Ehmann WD, Mao YX, Vance DE (1988) Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 9, 1-7.
41. Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM, Bloxham CA, Perry RH, Edwardson JA, Harrison PM (1992) Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochem J 287 (Pt 2), 509-514.
42. Samudralwar DL, Diprete CC, Ni BF, Ehmann WD, Markes-bery WR (1995) Elemental imbalances in the olfactory pathway in Alzheimer's disease. J Neurol Sci 130, 139-145.
43. Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA (1995) Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem 65, 710-724.
44. Kala SV, Hasinoff BB, Richardson JS (1996) Brain samples from Alzheimer's patients have elevated levels of loosely bound iron. Int J Neurosci 86, 263-269.
45. LeVine SM (1997) Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 760, 298-303.
46. Hautot D, Pankhurst QA, Khan N, Dobson J (2003) Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue. Proc Biol Sci 270 Suppl 1, S62-S64.
47. Collingwood JF, Mikhaylova A, Davidson M, Batich C, Streit WJ, Terry J, Dobson J (2005) In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J Alzheimers Dis 7, 267-272.
48. Honda K, Smith MA, Zhu X, Baus D, Merrick WC, Tartakoff AM, Hattier T, Harris PL, Siedlak SL, Fujioka H, Liu Q, Moreira PI, Miller FP, Nunomura A, Shimohama S, Perry G (2005) Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J Biol Chem 280, 20978-20986.
49. Hallgren B, Sourander P (1960) The non-haemin iron in the cerebral cortex in Alzheimer's disease. J Neurochem 5, 307-310.
50. Religa D, Strozyk D, Cherny RA, Volitakis I, Haroutunian V, Winblad B, Naslund J, Bush AI (2006) Elevated cortical zinc in Alzheimer disease. Neurology 67, 69-75.
51. Pinero DJ, Hu J, Connor JR (2000) Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains. Cell Mol Biol 46, 761-776.
52. Smith MA, Wehr K, Harris PL, Siedlak SL, Connor JR, Perry G (1998) Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res 788, 232-236.
53. Kong G, Miles L, Crespi G, Morton C, Ng H, Barnham K, McKinstry W, Cappai R, Parker M (2008) Copper binding to the Alzheimer's disease amyloid precursor protein. Eur Biophys J 37, 269-279.
54. Hentze MW, Caughman SW, Casey JL, Koeller DM, Rouault TA, Harford JB, Klausner RD (1988) A model for the structure and functions of iron-responsive elements. Gene 72, 201-208.
55. Rouault TA, Hentze MW, Dancis A, Caughman W, Harford JB, Klausner RD (1987) Influence of altered transcription on the translational control of human ferritin expression. Proc Natl Acad Sci USA 84, 6335-6339.
56. Bellingham SA, Lahiri DK, Maloney B, Fontaine SL, Multhaup G, Camakaris J (2004) Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene. J Biol Chem 279, 20378-20386.